pharma · Not applicable, Healthy Volunteers · advanced/metastatic non-squamous non-small cell lung cancer (NSCLC)
mAbxience
Mabxience Research SL
Mabxience Research SL is a pharma organization headquartered in Madrid, ES. Primary therapeutic focus areas include Not applicable, Healthy Volunteers, advanced/metastatic non-squamous non-small cell lung cancer (NSCLC),
madrid, ES HQ
2009 Founded
1,194 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- madrid, ES
- Founded
- 2009
- Employees
- 1,194
- Programs
- 5
- Drugs
- 10
- Patents
- 0
MB11-C-01-25
Phase 3 · small molecule · Previously Untreated Advanced (Unresectable or Metastatic) Melanoma
MB11-C-01-25 for Previously Untreated Advanced (Unresectable or Metastatic) Melanoma is a Phase 3 program (small_molecule) at Mabxience Research SL with 1 ClinicalTrials.gov record(s).
Internal code MB11-C-01-25
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Mabxience Research SL
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Previously Untreated Advanced (Unresectable or Metastatic) Melanoma
- Status
- active
- Trials
- 1